Pradeep Patni is a Chief Executive Officer, Indian Formulation at Wanbury, bringing extensive leadership experience and a strategic focus to the healthcare sector. Their career spans over 25 years, demonstrating a consistent ability to drive change and make a significant impact across diverse business environments.

With over a decade of experience managing independent business units within leading multinational pharmaceutical companies, Pradeep has cultivated a broad area of expertise encompassing both patented and generic molecules, as well as bio-therapeutics. They apply a data-driven approach to strategy, focusing on targeted efforts to optimize business outcomes. This approach has been instrumental in building products from the ground up and establishing them as leading solutions in the market. Their expertise extends to market analysis and brand management, contributing to revenue generation and portfolio management.

Prior to Wanbury, Pradeep served as Executive Vice President at Micro Labs Limited. Earlier in their career, they held the position of Director, Marketing & Sales at Pediasure. During their tenure at Pfizer, Pradeep held multiple BU Head positions, including Hospital Anti Infectives, Cardiovascular and Metabolic, Lifestyle, Insulin, and Specialty, demonstrating versatile leadership within a global pharmaceutical organization. Their responsibilities at Pfizer included oncology, antifungals, ophthalmology, endocrine care, and uro/gynecology. Before Pfizer, Pradeep was General Manager, Marketing at Janssen. Pradeep also served as Chief Executive Officer at Akumentis pharmaceutical.

Pradeep’s background includes a passion for developing people and transforming organizational culture. They hold a Master of Business Administration from the Indian Institute of Management, Bangalore, reflecting applied knowledge of business strategy and financial management